Benjamin R. Yerxa, Director at Clearside Biomedical, Inc. (CLSD), bought 7,813 shares at $1.31 ($10K) on 2024-05-15, disclosed to the SEC on 2024-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |
| ISPH | SELL | 2010-04-05 | $13K | — | Filing → |